Losartan potassium 10 MG/ML Oral Suspension [Arbli] — RxCUI 2709046
RxNorm drug concept · Semantic branded drug
RxCUI 2709046
Semantic branded drug · SBD
● Current RxNorm concept 1 FDA product
1 package NDC
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI2709046
Official nameLosartan potassium 10 MG/ML Oral Suspension [Arbli]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known aslosartan K+ 10 MG/ML Oral Suspension [Arbli]; Arbli 10 MG/mL Oral Suspension; Arbli 10 MG (equivalent to losartan 9.2 MG) per 1 mL Oral Suspension; losartan Pot 10 MG/ML Oral Suspension [Arbli]
FDA products mapped1
Package NDCs mapped1
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Losartan: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Losartan is mainly used to lower high blood pressure, which protects you from strokes and heart attacks over time. Depending on your situation, your doctor may also have prescribed...
- What exactly is losartan supposed to do for me?
- You can take losartan at any time of day that works for you, as long as you're consistent. Taking it with or without food is both fine — eating may slow things down a tiny bit, but...
- Does it matter what time of day I take it, and can I take it with food?
🕸️ Concept Web — How Losartan potassium 10 MG/ML Oral Suspension [Arb... Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Losartan potassium 10 MG/ML Oral Suspension [Arbli]
RxCUI 2709046 Semantic branded drug · SBD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 2
The active substance itself — no strength, form, or brand attached yet.
-
Losartan
52175IN -
Losartan potassium
203160PIN
-
Losartan
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Arbli
2709040BN
-
Arbli
-
Dose forms 13
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Losartan Oral Suspension
2709036SCDF -
Losartan potassium Oral Suspension
2709038SCDFP -
Losartan Oral Liquid Product
2709035SCDG -
Losartan Oral Product
1165342SCDG -
Losartan potassium Oral Liquid Product
2709037SCDGP -
Losartan potassium Oral Product
2659438SCDGP -
Losartan Oral Suspension [Arbli]
2709044SBDF -
Losartan potassium Oral Suspension [Arbli]
2709045SBDFP - +5 more in this family
-
Losartan Oral Suspension
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Losartan potassium 10 MG/ML Oral Suspension
2709039SCD -
Losartan potassium 10 MG/ML
2709034SCDC -
Losartan potassium 10 MG/ML [Arbli]
2709041SBDC
-
Losartan potassium 10 MG/ML Oral Suspension
Showing up to 8 concepts per family — 14 of 19 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Losartan potassium 10 MG/ML Oral Suspension
SCD · 2709039 -
Losartan potassium 10 MG/ML
SCDC · 2709034 -
Losartan Oral Suspension
SCDF · 2709036 -
Losartan potassium Oral Suspension
SCDFP · 2709038 -
Losartan Oral Liquid Product
SCDG · 2709035 -
Losartan Oral Product
SCDG · 1165342 -
Losartan potassium Oral Liquid Product
SCDGP · 2709037 -
Losartan potassium Oral Product
SCDGP · 2659438
Brand-Name Concepts
-
Losartan potassium 10 MG/ML [Arbli]
SBDC · 2709041 -
Losartan Oral Suspension [Arbli]
SBDF · 2709044 -
Losartan potassium Oral Suspension [Arbli]
SBDFP · 2709045 -
Arbli Oral Liquid Product
SBDG · 2709043 -
Arbli Oral Product
SBDG · 2709042 -
Arbli
BN · 2709040
📦 FDA Products & Package NDCs
1 product · 1 package NDC
1 package NDC map to RxCUI 2709046 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 83245-0053-06 | 1 BOTTLE in 1 CARTON (83245-053-06) / 165 mL in 1 BOTTLE | ARBLI | Scienture LLC | 2025-03-19 |
Observed labelers:
Scienture LLC (1)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.